Luca Fabris

11.3k total citations
129 papers, 4.5k citations indexed

About

Luca Fabris is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, Luca Fabris has authored 129 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Surgery, 50 papers in Hepatology and 34 papers in Oncology. Recurrent topics in Luca Fabris's work include Pediatric Hepatobiliary Diseases and Treatments (42 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (37 papers) and Liver physiology and pathology (22 papers). Luca Fabris is often cited by papers focused on Pediatric Hepatobiliary Diseases and Treatments (42 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (37 papers) and Liver physiology and pathology (22 papers). Luca Fabris collaborates with scholars based in Italy, United States and United Kingdom. Luca Fabris's co-authors include Mario Strazzabosco, Massimiliano Cadamuro, Carlo Spirlı̀, Romina Fiorotto, Valeria Mariotti, Lajos Okolicsànyi, Ruth Joplin, Simone Brivio, Maria Guido and Gianfranco Alpini and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Luca Fabris

124 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luca Fabris Italy 42 2.7k 1.7k 1.1k 950 885 129 4.5k
Vincenzo Cardinale Italy 35 2.5k 0.9× 1.3k 0.8× 825 0.7× 886 0.9× 645 0.7× 105 3.7k
Péter Nagy Hungary 33 1.7k 0.6× 2.3k 1.3× 809 0.7× 1.7k 1.8× 1.0k 1.2× 118 4.6k
Massimiliano Cadamuro Italy 31 1.4k 0.5× 703 0.4× 776 0.7× 747 0.8× 397 0.4× 93 2.6k
Petra Rümmele Germany 27 1.1k 0.4× 871 0.5× 851 0.7× 687 0.7× 479 0.5× 67 3.2k
Keiko Shiratori Japan 36 3.6k 1.4× 1.1k 0.7× 1.2k 1.1× 731 0.8× 3.3k 3.7× 201 6.3k
Shingi Imaoka Japan 37 2.1k 0.8× 1.3k 0.8× 2.2k 1.9× 1.6k 1.7× 1.1k 1.2× 190 5.9k
Wanguang Zhang China 28 797 0.3× 896 0.5× 682 0.6× 870 0.9× 523 0.6× 133 3.1k
Masahiro Tanemura Japan 35 1.9k 0.7× 495 0.3× 1.3k 1.1× 2.2k 2.3× 499 0.6× 222 4.8k
Alessandro Granito Italy 49 1.3k 0.5× 2.9k 1.7× 544 0.5× 411 0.4× 2.6k 3.0× 149 4.8k
Kunihito Gotoh Japan 36 1.5k 0.5× 844 0.5× 1.6k 1.4× 1.1k 1.2× 1.2k 1.3× 178 4.2k

Countries citing papers authored by Luca Fabris

Since Specialization
Citations

This map shows the geographic impact of Luca Fabris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Fabris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Fabris more than expected).

Fields of papers citing papers by Luca Fabris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Fabris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Fabris. The network helps show where Luca Fabris may publish in the future.

Co-authorship network of co-authors of Luca Fabris

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Fabris. A scholar is included among the top collaborators of Luca Fabris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Fabris. Luca Fabris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mura, Vincenzo La, Vincenzo Cardinale, Raimondo De Cristofaro, et al.. (2024). Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice. Blood Advances. 8(22). 5725–5734. 6 indexed citations
2.
Cadamuro, Massimiliano, Samantha Sarcognato, Giacomo Zanus, et al.. (2023). Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma. International Journal of Molecular Sciences. 24(5). 4748–4748. 4 indexed citations
3.
Yao, Yuelin, Paula Olaizola, Alexander Walker, et al.. (2023). A TGFβ-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease. Science Translational Medicine. 15(713). eabq5930–eabq5930. 9 indexed citations
4.
Cadamuro, Massimiliano, et al.. (2023). The tumor microenvironment in hepatocarcinoma: dissecting the functions of cancer-associated fibroblasts. Hepatoma Research. 4 indexed citations
5.
Gambella, Alessandro, Massimiliano Cadamuro, Marco Quaglia, et al.. (2023). The Landscape of HNF1B Deficiency: A Syndrome Not Yet Fully Explored. Cells. 12(2). 307–307. 9 indexed citations
6.
Pasqua, Laura Giuseppina Di, Marta Cagna, G. Palladini, et al.. (2023). FXR agonists INT‐787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet‐induced ob/ob mouse model of NASH. Liver International. 44(1). 214–227. 12 indexed citations
7.
Cadamuro, Massimiliano, Maria Guido, Samantha Sarcognato, et al.. (2022). Translational Value of Tumor-Associated Lymphangiogenesis in Cholangiocarcinoma. Journal of Personalized Medicine. 12(7). 1086–1086. 5 indexed citations
8.
Pinon, Michele, Alessandro Gambella, Silvia Deaglio, et al.. (2022). New case of syncytial giant-cell variant of hepatocellular carcinoma in a pediatric patient with HNF1B deficiency: does it fit with the syndrome?. BMJ Open Gastroenterology. 9(1). e001013–e001013. 3 indexed citations
9.
Fabris, Luca, Chiara Milani, Romina Fiorotto, et al.. (2022). Dysregulation of the Scribble/YAP/β‐catenin axis sustains the fibroinflammatory response in a PKHD1 −/− mouse model of congenital hepatic fibrosis. The FASEB Journal. 36(6). e22364–e22364. 5 indexed citations
10.
Carrara, A., Márcio Costa, Luca Fabris, et al.. (2021). CT scan structured report for the study of abdominal wall defects: a fast, easy and practical tool at the service of both surgeons and radiologist. Hernia. 25(6). 1685–1692. 1 indexed citations
11.
12.
Fabris, Luca, Keisaku Sato, Gianfranco Alpini, & Mario Strazzabosco. (2020). The Tumor Microenvironment in Cholangiocarcinoma Progression. Hepatology. 73(S1). 75–85. 147 indexed citations
13.
Fabris, Luca, María J. Perugorria, Joachim C. Mertens, et al.. (2019). The tumour microenvironment and immune milieu of cholangiocarcinoma. Liver International. 39(S1). 63–78. 122 indexed citations
14.
Carrara, A., et al.. (2018). Endo-laparoscopic reconstruction of the abdominal wall midline with linear stapler, the THT technique. Early results of the first case series. Annals of Medicine and Surgery. 38. 1–7. 20 indexed citations
15.
Cadamuro, Massimiliano, Simone Brivio, Carlo Spirlı̀, et al.. (2017). Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma. International Journal of Molecular Sciences. 18(1). 149–149. 30 indexed citations
16.
Carbone, Marco, Laura Cristoferi, Paolo Angelo Cortesi, et al.. (2017). Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(4). 1415–1422. 3 indexed citations
17.
Cadamuro, Massimiliano, Luisa Sambado, Stefano Indraccolo, et al.. (2016). Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma. Cancer Research. 76(16). 4775–4784. 43 indexed citations
18.
Brivio, Simone, Massimiliano Cadamuro, Luca Fabris, & Mario Strazzabosco. (2015). Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?. Journal of Clinical Medicine. 4(12). 2028–2041. 35 indexed citations
19.
Okolicsanyi, S., Manuel Gentiluomo, Paolo Angelo Cortesi, et al.. (2013). Generation and Performance of Outcome Indicators in Liver Disease: The Value Based Medicine in Hepatology Study (VBMH). Hepatology. 58. 2 indexed citations
20.
Spirlı̀, Carlo, Luca Fabris, Elena Duner, et al.. (2003). Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes. Gastroenterology. 124(3). 737–753. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincenzo Cardinale Breakdown of academic impact, for papers by Péter Nagy Breakdown of academic impact, for papers by Massimiliano Cadamuro Breakdown of academic impact, for papers by Petra Rümmele Breakdown of academic impact, for papers by Keiko Shiratori Breakdown of academic impact, for papers by Shingi Imaoka Breakdown of academic impact, for papers by Wanguang Zhang Breakdown of academic impact, for papers by Masahiro Tanemura Breakdown of academic impact, for papers by Alessandro Granito Breakdown of academic impact, for papers by Kunihito Gotoh
Rankless by CCL
2026